Written Question·Department of Health and Social Care·UIN 20760
Pancreatic Enzyme Replacement Therapy
Tabled: 17 December 2024
Answered: 6 January 2025
Named DayQuestion
Mike Martin
Liberal Democrat — Tunbridge Wells
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of establishing a British supplier of Creon.
Answer
Karin SmythThe Department has been working with suppliers to address current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy (PERT) used by patients with conditions such as cystic fibrosis and certain cancers, including pancreatic...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 20760) →